QOL and Mental Health Using APD With Remote Monitoring System
The Investigation of Quality of Life and Mental Health Using Remote Monitoring System (Sharesource) With Automated Peritoneal Dialysis in End-stage Renal Disease Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
Although peritoneal dialysis (PD) is a representative renal replacement therapy along with hemodialysis, number of PD patients decreases every year. Among the various contributing factors for such trends, the essential issue that the patients should perform dialytic therapy by themselves is thought to be critical for the patients to avoid choosing PD as primary dialytic therapy. In particular, unlike hemodialysis, the patients with PD have troubles in getting timely medical advice in their daily life, although continuous advice are essential for maintaining therapy. Thus, remote monitoring and control system is believed to be useful in PD therapy. Automated PD (APD) is a good option because of its convenience and improved accessibility. So, in Korea, although the rate of incident PD patients was decreased, the proportion of APD were rapidly increased (3.7% in 2001 vs. 39% in 2018, Korean Society of Nephrology (KSN) data) In the COVID-19 pandemic, the investigators should improve Remote therapy monitoring (RTM). Technologies that collect medical information and transmit it to health care providers for patient management, have the potential to improve the patients' outcomes without visiting hospital receiving automated peritoneal dialysis (APD) at home. However, there are only a few retrospective studies and no prospective study about remote patients monitoring programs in APD. Remote medical service is currently illegal in South Korea. However, recently the Korean government has approved remote medical service in only a few areas of Gangwon province, including Wonju city, which belongs to our institution. Thus, the investigators aim to use such a benefit to investigate the 'Quality of Life (QOL)' in Korean patients undergoing APD. The investigators plan to compare the various clinical indexes, including mainly QOL, mental health focusing depression, and volume-nutritional status between the patients with previous classic APD and APD combined by the SharesourceTM system (Baxter Co.).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable quality-of-life
Started Dec 2025
Shorter than P25 for not_applicable quality-of-life
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2025
CompletedFirst Posted
Study publicly available on registry
June 10, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJune 10, 2025
June 1, 2025
29 days
February 24, 2025
June 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
changes of quality of life KDQOL-36
6, 12 months
changes of quality of life PHQ-9
6, 12 months
changes of quality of life BDI
6, 12 months
changes of quality of life CESD
6, 12 months
Secondary Outcomes (6)
change volume status
6, 12 months
change nutrition status
6, 12 months
dialysis adequacy
6,12 months
Questionnaire form.
6,12 months
adverse events
12 months
- +1 more secondary outcomes
Other Outcomes (2)
Total time or PD
90 Days
Medical coast of treatment
12 month
Study Arms (2)
APD with Sharesource
EXPERIMENTALPatients received APD with Sharesource system
APD without Sharesource
PLACEBO COMPARATORPatients received APD without sharesource
Interventions
Patients receive APD with an FMC device that contains sharesource software which can communicate with the medical team.
Patients received APD with Same machine but this patients dose not using sharesource software
Eligibility Criteria
You may qualify if:
- More than 18 years old
- ESRD patients on APD(≥1 month)
- Consent to participate in the study
You may not qualify if:
- Patients who plan to receive kidney transplantation within 1 year
- Patients with co-morbidities: cardiovascular disease(myocardial infarction, heart failure, arrhythmia), cancer, psychiatric diseases, liver cirrhosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wonju Severance Christian Hospital
Wŏnju, Kangwondo, 26426, South Korea
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2025
First Posted
June 10, 2025
Study Start
December 1, 2025
Primary Completion
December 30, 2025
Study Completion
December 31, 2025
Last Updated
June 10, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share